https://www.morganstanley.com/im/fr-fr/intermediary-investor/companies/cytyc.html
Cytyc | Morgan Stanley
Cytyc (NASDAQ:CYTC) develops diagnostic systems for cervical cancer screening.
morganstanley
https://www.morganstanley.com/im/en-us/institutional-investor/companies/cytyc.html
Cytyc | Morgan Stanley
Cytyc (NASDAQ:CYTC) develops diagnostic systems for cervical cancer screening.
morganstanley
https://www.ftc.gov/news-events/news/press-releases/2002/06/ftc-seeks-block-cytyc-corps-acquisition-digene-corp
FTC Seeks to Block Cytyc Corp.'s Acquisition of Digene Corp. | Federal Trade Commission
Aug 20, 2025 - The Federal Trade Commission today authorized staff to seek a preliminary injunction to block Cytyc Corporation's (Cytyc) proposed $420 million acquisition of...